Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture

Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the newly emergent causative agent of coronavirus disease-19 (COVID-19), has resulted in more than two million deaths worldwide since it was first detected in 2019. There is a critical global need for therapeutic intervention strategies t...

Full description

Bibliographic Details
Main Authors: Allison Bakovic, Kenneth Risner, Nishank Bhalla, Farhang Alem, Theresa L. Chang, Warren K. Weston, Jane A. Harness, Aarthi Narayanan
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Viruses
Subjects:
brilacidin
coronavirus
antiviral
defensin
peptidomimetic
entry inhibition
Online Access:https://www.mdpi.com/1999-4915/13/2/271

Similar Items

Similar Items